Clara Maluquer

648 total citations
10 papers, 27 citations indexed

About

Clara Maluquer is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Clara Maluquer has authored 10 papers receiving a total of 27 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hematology, 5 papers in Genetics and 4 papers in Oncology. Recurrent topics in Clara Maluquer's work include Chronic Lymphocytic Leukemia Research (4 papers), Multiple Myeloma Research and Treatments (4 papers) and Lymphoma Diagnosis and Treatment (3 papers). Clara Maluquer is often cited by papers focused on Chronic Lymphocytic Leukemia Research (4 papers), Multiple Myeloma Research and Treatments (4 papers) and Lymphoma Diagnosis and Treatment (3 papers). Clara Maluquer collaborates with scholars based in Spain and United States. Clara Maluquer's co-authors include Mireia Morgades, José González‐Campos, Natalia Alonso, Josep‐María Ribera, Jordi Juncà, Isabel Granada, Pau Montesinos, Ramón García‐Sánz, Anna Torrent and Lurdes Zamora and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and British Journal of Haematology.

In The Last Decade

Clara Maluquer

8 papers receiving 26 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Clara Maluquer Spain 3 21 14 9 8 8 10 27
Chloé Arfeuille France 5 21 1.0× 14 1.0× 5 0.6× 16 2.0× 5 0.6× 11 46
R Mataix Spain 3 24 1.1× 10 0.7× 9 1.0× 7 0.9× 8 1.0× 8 34
А. С. Лучинин Russia 4 22 1.0× 5 0.4× 7 0.8× 8 1.0× 12 1.5× 14 37
Anupa Kudva United States 4 12 0.6× 10 0.7× 11 1.2× 4 0.5× 5 0.6× 6 34
Sumithra Vasu United States 5 42 2.0× 8 0.6× 10 1.1× 19 2.4× 7 0.9× 9 49
I-Ming L. Chen United States 4 22 1.0× 22 1.6× 2 0.2× 6 0.8× 6 0.8× 7 32
Paola Bonaccorso Italy 3 14 0.7× 12 0.9× 4 0.4× 18 2.3× 4 0.5× 11 33
Kristi Romero United States 3 21 1.0× 5 0.4× 5 0.6× 6 0.8× 8 1.0× 7 27
Nahal Lalefar United States 4 22 1.0× 5 0.4× 7 0.8× 4 0.5× 5 0.6× 7 27
Rosa Adaeva France 3 26 1.2× 4 0.3× 11 1.2× 9 1.1× 4 0.5× 4 35

Countries citing papers authored by Clara Maluquer

Since Specialization
Citations

This map shows the geographic impact of Clara Maluquer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clara Maluquer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clara Maluquer more than expected).

Fields of papers citing papers by Clara Maluquer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clara Maluquer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clara Maluquer. The network helps show where Clara Maluquer may publish in the future.

Co-authorship network of co-authors of Clara Maluquer

This figure shows the co-authorship network connecting the top 25 collaborators of Clara Maluquer. A scholar is included among the top collaborators of Clara Maluquer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clara Maluquer. Clara Maluquer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Ruiz‐Xivillé, Neus, Lurdes Zamora, Susana Vives, et al.. (2024). Identification of novel NUP98 fusion partners and comutations in acute myeloid leukemia: an adult cohort study. Blood Advances. 8(11). 2691–2694. 6 indexed citations
2.
Ribera, Josep‐María, Mireia Morgades, Pau Montesinos, et al.. (2024). Ponalfil trial for adults with Philadelphia chromosome‐positive acute lymphoblastic leukemia: Long‐term results. HemaSphere. 8(4). e67–e67. 10 indexed citations
3.
Pomares, Helena, Francesca Guijarro, Mònica López‐Guerra, et al.. (2023). Characteristics and long‐term outcome in a large series of chronic myelomonocytic leukaemia patients including 104 formerly referred to as oligomonocytic. British Journal of Haematology. 204(3). 892–897. 3 indexed citations
4.
Arribas, Ignacio, Clara Maluquer, Helena Pomares, et al.. (2023). B-cell acute lymphoblastic leukemia after lenalidomide maintenance therapy; a deleterious adverse event that needs further investigation. Report of three cases and review of the literature. Leukemia & lymphoma. 64(10). 1701–1705. 1 indexed citations
5.
Pomares, Helena, Susana Vives, Rosa Coll, et al.. (2021). Venetoclax Combination Therapy in Relapsed/Refractory Acute Myeloid Leukemia. Blood. 138(Supplement 1). 4421–4421.
6.
Senín, Alicia, et al.. (2021). Dose intensity and treatment duration of bortezomib in transplant‐ineligible newly diagnosed multiple myeloma. European Journal Of Haematology. 107(2). 246–254. 2 indexed citations
7.
Climent, Fina, Dolors Colomer, Mònica López‐Guerra, et al.. (2020). Clonal relationship in multisited mucosa‐associated lymphoid tissue lymphomas: a single‐centre experience. British Journal of Haematology. 192(6). 1020–1025.
8.
Maluquer, Clara, Beatríz Bellosillo, Alberto Mussetti, et al.. (2020). Liquid biopsy for disease monitoring after anti‐CD19 chimeric antigen receptor T cell in diffuse large B‐cell lymphoma. SHILAP Revista de lepidopterología. 2(1). 109–111. 2 indexed citations
10.
Sorigué, Marc, Clara Maluquer, & Jordi Juncà. (2017). Phenotypic Characterization of Trisomy 12 Monoclonal B‐Cell Lymphocytosis. Cytometry Part B Clinical Cytometry. 94(2). 374–378. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026